Compare GangaGen vs Human Genome Sciences
Customers evaluate the quality of GangaGen's products using the following success metrics.
Overview
GangaGen is 23 yrs old and is based in India.
GangaGen is a biotechnology company focused on the development of products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences.
Human Genome Sciences is 32 yrs old and is based in United States.
Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reductions in dosage, injection frequency, side effects, and overall cost of treatment. In July 2012, Human Genome Sciences was acquired by GlaxoSmithKline. The valuation of Human Genome Sciences was $3.6 billion.
Demo Video
Leadership
Janakiraman Ramachandran (Chief Executive Officer)
Craig C Parker (Managing General Partner)
Investors
CARB-X, Otsuka Holdings
GSK and Rho Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because GangaGen has not claimed their profile.
Work for GangaGen? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for GangaGen?
Claim your profile now.
Information not available because Human Genome Sciences has not claimed their profile.
Work for Human Genome Sciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Human Genome Sciences?
Claim your profile now.